Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53.
Checkpoint kinase 1 (Chk1) is a key element in the DNA-damage response pathway that is required for maintaining genomic stability. To study the potential role of Chk1 in mammary tumorigenesis, we disrupted it using a Cre/loxP system. We showed that although Chk1 heterozygosity caused abnormal development of the mammary gland, it was not sufficient to induce tumorigenesis. Simultaneous deletion of one copy of p53 failed to rescue the developmental defects; however, it synergistically induced mammary tumor formation in Chk1(+/-);MMTV-Cre animals with a median time to tumor latency of about 10 months. Chk1 deficiency caused a preponderance of abnormalities, including prolongation, multipolarity, misalignment, mitotic catastrophe and loss of spindle checkpoint, that are accompanied by reduced expression of several cell cycle regulators, including Mad2. On the other hand, we also showed that Chk1 deficiency inhibited mammary tumor formation in mice carrying a homozygous deletion of p53, uncovering a complex relationship between Chk1 and p53. Furthermore, inhibition of Chk1 with a specific inhibitor, SB-218078, or acute deletion of Chk1 using small hairpin RNA killed mammary tumor cells effectively. These data show that Chk1 is critical for maintaining genome integrity and serves as a double-edged sword for cancer: although its inhibition kills cancer cells, it also triggers tumorigenesis when favorable mutations are accumulated for cell growth.
Fishler
T
T
Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, MD, USA.
Li
Y-Y
YY
Wang
R-H
RH
Kim
H-S
HS
Sengupta
K
K
Vassilopoulos
A
A
Lahusen
T
T
Xu
X
X
Lee
M-H
MH
Liu
Q
Q
Elledge
S-J
SJ
Ried
T
T
Deng
C-X
CX
D000818:Animals; D001483:Base Sequence; D000071877:Checkpoint Kinase 1; D017931:DNA Primers; D042822:Genomic Instability; D008325:Mammary Neoplasms, Experimental / Q000235:genetics* / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D011494:Protein Kinases / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D032681:Spectral Karyotyping; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
D017931:DNA Primers; D016159:Tumor Suppressor Protein p53; D011494:Protein Kinases; D000071877:Checkpoint Kinase 1; C000605869:Chek1 protein, mouse
Methods Mol Biol. 2004;280:185-200
15187254
Nat Genet. 2001 Dec;29(4):418-25
11694875
Cancer Cell. 2005 Feb;7(2):193-204
15710331
Nature. 2004 Nov 18;432(7015):316-23
15549093
Nucleic Acids Res. 1997 Nov 1;25(21):4323-30
9336464
Oncogene. 2006 Nov 16;25(54):7148-58
16715125
Cancer Cell. 2005 Nov;8(5):353-4
16286243
Cancer Res. 2000 Feb 1;60(3):566-72
10676638
Cell. 1993 Nov 19;75(4):817-25
8242752
Nature. 1995 Oct 12;377(6549):552-7
7566157
Oncogene. 2001 Nov 8;20(51):7514-23
11709723
Oncogene. 1998 Dec 17;17(24):3115-24
9872327
Nat Genet. 2002 Mar;30(3):285-9
11836499
Cell Cycle. 2005 Jul;4(7):927-9
15970699
Nat Genet. 2001 Jul;28(3):266-71
11431698
Oncogene. 2007 Nov 8;26(51):7204-12
17496925
Cancer Cell. 2004 Jul;6(1):45-59
15261141
Cell. 1988 Jul 1;54(1):105-15
2898299
J Biol Chem. 2003 Jun 13;278(24):21767-73
12676925
J Cell Biochem. 2001;83(4):521-31
11746496
Science. 1994 Nov 4;266(5186):807-10
7973635
Mol Cell. 1999 Mar;3(3):389-95
10198641
Genes Dev. 2000 Jun 15;14(12):1448-59
10859164
Mol Cell Biol. 2005 Sep;25(17):7889-99
16107732
Cancer Res. 1998 Aug 1;58(15):3248-53
9699650
Ann Oncol. 2006 Feb;17(2):334-40
16284058
Dev Cell. 2007 Feb;12(2):247-60
17276342
Cell Cycle. 2008 Jun 1;7(11):1668-77
18469532
Cell. 1995 Aug 25;82(4):675-84
7664346
J Cell Mol Med. 2009 Aug;13(8A):1565-76
19778378
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5159-64
19289837
Genes Dev. 2000 Jun 15;14(12):1439-47
10859163
Oncogene. 2006 Jul 27;25(32):4381-8
16732333
Dev Cell. 2001 Aug;1(2):227-37
11702782
Cell. 2000 Jun 9;101(6):635-45
10892650
J Clin Oncol. 2005 Mar 20;23(9):1875-84
15699481
Curr Drug Targets. 2005 May;6(3):325-35
15857291
Cancer Cell. 2003 May;3(5):421-9
12781359
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14795-800
12399544
J Cell Biol. 2001 Sep 3;154(5):925-36
11535616
Nat Protoc. 2006;1(6):3129-42
17406576
Nature. 2001 Jan 18;409(6818):355-9
11201745
Science. 1994 Oct 7;266(5182):66-71
7545954
Nucleic Acids Res. 2006 Mar 06;34(5):1416-26
16522651
Cell. 1993 Nov 19;75(4):805-16
8242751
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17108-13
15563594
Oncogene. 2001 Mar 22;20(12):1445-54
11313888
Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R113-23
12668603